Komen Foundation Announces 1998 Postdoctoral Fellows

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 8
Volume 7
Issue 8

DALLAS--The Susan G. Komen Breast Cancer Foundation has announced the recipients of its 1998 postdoctoral fellowship grants, which total more than $1 million. In addition to these 10 new first-year grant recipients, the Komen Foundation currently funds 21 previously awarded fellowships throughout the United States.

DALLAS--The Susan G. Komen Breast Cancer Foundation has announced the recipients of its 1998 postdoctoral fellowship grants, which total more than $1 million. In addition to these 10 new first-year grant recipients, the Komen Foundation currently funds 21 previously awarded fellowships throughout the United States.

These fellowships represent the Foundation’s continued commitment to recruiting and retaining young scientists in the field of breast cancer research and to funding innovative, cutting-edge research. For example, a 1997 grant went to Wei Wen, PhD, and her sponsor Judah Folkman, MD, for further study of the angiogenesis inhibitor endostatin.

Each year, the Foundation’s National Research Fellowship Program offers postdoctoral fellowship grants for breast cancer research to qualified applicants with MD or PhD degrees.

The 3-year grant offers an experienced breast cancer investigator the opportunity to select a postdoctoral fellow to train in his or her laboratory. Grant recipients are selected through a peer-review process that is recognized by the National Cancer Institute. The annual stipend is $35,000 per award.

For more information about the grants program, contact Elda Railey, director of grants, via email at grants@komen.org or by calling 888-300-5582.

Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey K. Anders, MD, an expert on breast cancer
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table
Related Content